Literature DB >> 21912763

What made Canada become a country with the highest incidence of inflammatory bowel disease: could sucralose be the culprit?

Xiaofa Qin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912763      PMCID: PMC3202359          DOI: 10.1155/2011/451036

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  9 in total

1.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

2.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

Authors:  Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

3.  Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats.

Authors:  Mohamed B Abou-Donia; Eman M El-Masry; Ali A Abdel-Rahman; Roger E McLendon; Susan S Schiffman
Journal:  J Toxicol Environ Health A       Date:  2008

Review 4.  Epidemiological aspects of Crohn's disease: a review of the literature.

Authors:  J F Mayberry; J Rhodes
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

5.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.

Authors:  J H Gollop; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

6.  Inflammatory bowel disease in northern Alberta. An epidemiologic study.

Authors:  B R Pinchbeck; J Kirdeikis; A B Thomson
Journal:  J Clin Gastroenterol       Date:  1988-10       Impact factor: 3.062

7.  Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease.

Authors:  X F Qin
Journal:  Med Hypotheses       Date:  2002-08       Impact factor: 1.538

Review 8.  The development and applications of sucralose, a new high-intensity sweetener.

Authors:  I Knight
Journal:  Can J Physiol Pharmacol       Date:  1994-04       Impact factor: 2.273

9.  Epidemiology of IBD during the twentieth century: an integrated view.

Authors:  Vibeke Binder
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-06       Impact factor: 3.043

  9 in total
  4 in total

1.  How to explain recent multiple reports on the decline of inflammatory bowel disease in Canada.

Authors:  Xiaofa Qin
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

Review 2.  Etiology of inflammatory bowel disease: a unified hypothesis.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

3.  Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease.

Authors:  Md Sharif Shajib; Usha Chauhan; Salman Adeeb; Yeshale Chetty; David Armstrong; Smita L S Halder; John K Marshall; Waliul I Khan
Journal:  J Can Assoc Gastroenterol       Date:  2018-08-10

Review 4.  Structure-Dependent Activity of Plant-Derived Sweeteners.

Authors:  Serhat Sezai Ҫiçek
Journal:  Molecules       Date:  2020-04-22       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.